Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The following chart lists examples of mild ... In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Earlier, he had discovered that another class of drugs against type 2 diabetes, the so-called SGLT2 inhibitors, also appeared to work well for patients with chronic kidney damage without diabetes.

The findings add to a growing list of other health benefits researchers are studying related to the medications, which target ...

Ozempic, the trade name for semaglutide, is a once-a-week injectable medication in the class of GLP-1 receptor agonists used to lower blood sugar levels in people with type 2 diabetes. Doses start ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

branded as Mounjaro for diabetes and Zepbound for weight loss. The products, members of the extremely popular and effective class of GLP-1 drugs, had been on the shortage list since December 2022.

In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C ... ...

She was a fellow of the Association of Health Care Journalists’ 2020 class on Women ... the weight loss and diabetes drugs Mounjaro and Zepbound, from its shortage list. Removal from the ...

Weight-loss drugs ... list of other health benefits researchers are studying related to the medications, which target hormones called incretins that affect not just appetite, digestion, and ...